CIP
BIVV

Convergence Investment Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Convergence Investment Partners’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-18,763
Closed -$1.01M – 1090
2017
Q4 		$1.01M Sell
18,763
-4,567
-20% -$250K 0.14% 240
2017
Q3 		$1.33M Buy
23,330
+7,839
+51% +$459K 0.19% 207
2017
Q2 		$932K Buy
+15,491
New +$882K 0.14% 249

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Convergence Investment Partners's BIVV Position: Q1 2018 in Review

Convergence Investment Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 18,763 shares — an estimated $1.01M sold.

Convergence Investment Partners first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $1.33M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Convergence Investment Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Convergence Investment Partners sold 18,763 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.01M.
  • Convergence Investment Partners first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Convergence Investment Partners's Bioverativ Inc. Common Stock position peaked at $1.33M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Convergence Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.